Back

SGLT2 Inhibitor related polycythaemia: a potential severe side effect.

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure 1 Chronic Heart Failure HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Mr Martijn Tukker

Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Patent ductus arteriosus: an unexpected diagnosis at the adulthood
Doctor F. Duarte (Ponta Delgada, PT)
Slides Video
Presentation thumbnail
Cardiotoxicity? Systematic sclerosis? in quest of answers.
Doctor P. Kourkoveli (Maroussi-Athens, GR)
Slides Video
Presentation thumbnail
Monitoring of volume status using a novel sensor for the assessment of inferior vena cava area and collapsibility in a patient with HFrEF receiving advanced heart failure therapy a case study.
Professor F. Malek (Prague, CZ)
Slides Video
Presentation thumbnail
Measuring the Acute Effects of Cardiac Contractility Modulation (CCM) Therapy with a Non-Invasive Bioimpedance Hemodynamic System (NICaS)
Doctor A. Madeo (Castrovillari, IT)
Slides Video

Access the full session

Session thumbnail
Chronic heart failure 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Secondary erythrocytosis / polycythemia due to sodium glucose co-transporter 2 inhibitors: a real world heart failure cohort.
thumbnail
Congress Presentation
Potential hematopoietic effects of SGLT2 inhibitors in patients with cardiac amyloidosis.
thumbnail
Congress Presentation
Effect of sodium-glucose co-transporter-2 inhibitor on estimated plasma volume as assessed by biomarkers of hemoconcentration in non-diabetic patient with HFrEF and HFpEF case studies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources